Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

Mahmut Emre YildirimNuri Karadurmuşİlker Nihat ÖktenHacı Mehmet TürkZuhat UrakciÇağatay ArslanSinemis ÇelikFaysal DaneMehmet Ali Nahit ŞendurCemil BilirBülent KarabulutIrfan Cicin Erdem CubukcuMustafa KaracaMelike Ozcelik Mustafa YıldırımEda TanrikuluAhmet AlacaciogluÖzgür AçıkgözBaşak ÖvenÇağlayan GeredeliTimucin ÇilHakan HarputluoğluUmut KefeliOktay BozkurtDeniz Tural Abdullah SakinŞuayip YalçınMahmut Gumus

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)

According to the results of our real-life data study, there is no significant difference in efficiency between the combination of biological agent and chemotherapy used in the second-line treatments.

Keyphrases

wild type
electronic health record
locally advanced
cross sectional
radiation therapy
machine learning
rectal cancer